Form EFFECT Blueprint Medicines Corp

July 25, 2025 6:02 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 24, 2025
Accession Number: 0001193125-25-161191
Submission Type: POS AM
CIK: 0001597264
Company Name: Blueprint Medicines Corp
File Number: 333-211266


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings